The Seattle Times

JOHN LOK / THE SEATTLE TIMES
Advertising

Saturday, November 25, 2006

Tackling diseases that devastate the poor

IDRI has developed the first vaccine against leishmaniasis, a disease that affects 150 million people in 88 countries.